English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

OBJETIVO: analisar alterações macroscópicas e histológicas que ocorrem com o uso da sinvastatina em endometriose experimental em ratas. MÉTODOS: quarenta ratas da linhagem Wistar foram submetidas à técnica de autotransplante uterino em mesentério. Após três semanas, 24 ratas desenvolveram endometriose experimental grau III e foram divididas em dois grupos: Sinvastatina (dado 20 mg/kg/dia via oral) e Controle (dado cloreto de sódio a 0,9% na quantidade de 1 mL/100 g de peso corpóreo via oral), que receberam gavagem durante 14 dias seguido de morte. Os volumes dos implantes foram calculados [4pi (comprimento/2) x (largura/2) x (altura/2)/3] nas intervenções cirúrgicas e após a morte dos animais. Os autotransplantes foram retirados, corados com a hematoxilina-eosina e analisados à microscopia de luz. Foram usados o teste de Mann-Whitney para amostras independentes e o teste de Wilcoxon para amostras relacionadas. Para avaliação histológica, foi usado o teste exato de Fisher, adotando-se nível de significância de 5%. RESULTADOS: a diferença entre os volumes médios iniciais dos autotransplantes nos dois grupos foi insignificante (p=1,00), e, entre os volumes médios finais, significante (p=0,04). Houve aumento significativo (p=0,01) entre os volumes médios iniciais e finais do Grupo Controle e redução insignificante no Grupo Sinvastatina (p=0,95). Histologicamente (p=0,64), o Grupo Sinvastatina (n=9) mostrou a parede epitelial moderadamente preservada em sete casos (77,80%) e dois casos com camada epitelial bem preservada (22,2%), e o Grupo Controle (n=12) com sete casos (58,30%) moderadamente preservados e cinco casos (41,70%) bem preservados. CONCLUSÕES: a sinvastatina impediu o crescimento dos focos de endometriose experimental. São promissores os estudos com uso da sinvastatina por período mais prolongado. PURPOSE: to analyze the macroscopic and histological changes that occur with the use of sinvastatin in experimental endometriosis in female rats. METHODS: forty Wistar female rats were submitted to the technique of uterine self-transplant in mesenterium. After three weeks, 24 of them developed experimental endometriosis grade III, and were divided in two groups: one group received sinvastatin orally (20 mg/kg/day) and the other (control group) received 0.9% of sodium chloride orally (1 mL/100 g of body weight/day). Both groups received gavage for 14 days, followed by death. The implant volume was calculated [4pi (lenght/2) x (width/2) x (height/2)/3] at the surgical intervention and after the animal’s death. The self-transplants were removed, dyed with hematoxylin-eosin and analyzed by light microscopy. The Mann-Whitney’s test was used in the independent samples and the Wilcoxon’s test for the related samples. The Fisher’s exact test was used for the histological evaluation, with a significance level of 5%. RESULTS: the difference between groups of the initial average volumes of the self-transplants was not significant (p=1.00), but became significant for the final average volumes (p=0.04). There was a significant increase (p=0.01) between the initial and final average volumes in the control group, and a no significant decrease in the sinvastatin group (p=0.95). Histologically, the sinvastatin group (n=9) presented seven cases (77.8%) of moderately preserved and two cases (22.2%) of well preserved epithelial wall, while the control group (n=12) presented seven cases (58.3%) of moderately preserved and five cases (41.7%) of well preserved epithelial wall. CONCLUSIONS: sinvastatin prevented the growth of experimental endometriosis. Studies with sinvastatin for longer periods are promising

Modificações do volume e da histologia de focos de endometriose em ratas tratadas com sinvastatina